| CAT | 8-K | bullish | 6/10 | Caterpillar reported Q3 2026 sales and revenues of $20.7 billion, up 17% YoY, and GAAP EPS of $7.13, up 46% YoY from $4. | Oct 29, 2026 |
| BFLY | 8-K | bullish | 5/10 | Butterfly Network reported Q3 2026 revenue of $32.6M (+52% YoY), beating the $28.3M consensus, with record gross margin | Oct 29, 2026 |
| BAND | 8-K | neutral | 2/10 | Bandwidth Inc. appointed Charles R. "Chip" Schroeder, a former Silver Lake managing director, to its board of directors, | Oct 29, 2026 |
| ARES | PRESS-RELEASE | neutral | 5/10 | Ares Management Corporation announced Q3 2026 fee-related earnings of $524.2M (up 11% YoY) and after-tax realized income | Oct 29, 2026 |
| NCLH | PRESS-RELEASE | neutral | 2/10 | Norwegian Cruise Line Holdings announced that Chief Strategy Officer Meghan Montana will become CFO effective January 1, | Oct 29, 2026 |
| FTRE | PRESS-RELEASE | bullish | 6/10 | Fortrea reported Q3 2026 adjusted EPS of $0.28, beating the $0.22 consensus by 27.3%, and revenue of $691.5M, above the | Oct 29, 2026 |
| NCLH | PRESS-RELEASE | bullish | 6/10 | Norwegian Cruise Line reported Q3 2026 revenue of $2.9B and adjusted EPS of $1.12, beating the consensus estimate of $0. | Oct 29, 2026 |
| CCB | PRESS-RELEASE | neutral | 5/10 | Coastal Financial returned to profitability in Q3 2026 with net income of $13.8M ($0.89 diluted EPS), recovering from a | Oct 29, 2026 |
| DGICA | PRESS-RELEASE | neutral | 5/10 | Donegal Group reported Q3 2026 GAAP EPS of $0.49, beating the $0.43 consensus by 13.9%, but net premiums earned fell 3.0 | Oct 29, 2026 |
| BMGL | 6-K | bearish | 6/10 | Basel Medical Group Ltd disclosed that warrant holders exercised 6,000,000 Common Warrants using the zero-cash exercise | Oct 29, 2026 |
| BWA | PRESS-RELEASE | neutral | 5/10 | BorgWarner reported Q3 2026 adjusted EPS of $1.39, beating the $1.25 consensus by 11.2%, while revenue of $3.487B slight | Oct 29, 2026 |
| DGICA | 8-K | bearish | 4/10 | Donegal Group reported Q3 2026 net income of $18.2M ($0.49 diluted Class A), down 9.6% from $20.1M ($0.55) a year ago, a | Oct 29, 2026 |
| UBS | 6-K | bullish | 6/10 | UBS reported strong Q3 2026 results with net profit of $2.7 billion and EPS of $0.85, underlying PBT up 14% to $4.1 bill | Oct 29, 2026 |
| VEON | PRESS-RELEASE | neutral | 4/10 | VEON's Ukrainian subsidiary Kyivstar announced the acquisition of GigaCloud, a Ukrainian cloud infrastructure provider, | Oct 29, 2026 |
| FRHC | 8-K | neutral | 5/10 | Freedom Holding Corp. entered into an investment agreement for a $1.16 billion bond issuance by a wholly-owned subsidiar | Oct 29, 2026 |
| FTAI | 8-K | bullish | 6/10 | FTAI Aviation reported Q3 2026 net income of $149.1M (up 26.8% QoQ) and consolidated Adjusted EBITDA of $348.3M (up 14.8 | Oct 29, 2026 |
| CPAC | 6-K | neutral | 4/10 | Cementos Pacasmayo disclosed that the Peruvian securities regulator (SMV) issued a formal letter to Inversiones ASPI (Ho | Oct 29, 2026 |
| NCI | 6-K | neutral | 3/10 | Shareholders of Neo-Concept International Group Holdings Ltd approved two resolutions at an Extraordinary General Meetin | Oct 29, 2026 |
| ASX | 6-K | bullish | 6/10 | ASE Technology reported Q3 2026 results with net revenue of NT$244,161 million, up 44.8% year-over-year, and net income | Oct 29, 2026 |
| RAASY | SC 13D/A | mixed | 7/10 | TB Alternative Assets Ltd. and other reporting persons filed this final amendment to Schedule 13D to report that, follow | Oct 29, 2026 |
| ABEV | 6-K | neutral | 4/10 | Ambev S.A. announced a share buyback program authorizing the repurchase of up to 190,000,000 common shares (approximatel | Oct 29, 2026 |
| KB | 6-K | neutral | 2/10 | KB Financial Group's board declared a quarterly cash dividend of KRW 1,167 per common share, totaling approximately KRW | Oct 29, 2026 |
| FRBT | 8-K | bullish | 6/10 | Forbright, Inc. reported Q3 2026 diluted EPS of $0.41, above the $0.34 consensus, and total revenue of $101.1M, above th | Oct 29, 2026 |
| KB | 6-K | neutral | 2/10 | KB Financial Group designated November 12, 2026 as the record date for its third-quarter interim cash dividend. The fili | Oct 29, 2026 |
| HCM | 6-K | neutral | 4/10 | HUTCHMED announced that the US FDA granted Orphan Drug Designation to sovleplenib for primary immune thrombocytopenia (I | Oct 29, 2026 |
| DJT | S-4/A | neutral | 5/10 | Trump Media & Technology Group Corp. (TMTG) filed Amendment No. 1 to its S-4 registration statement for the proposed all | Oct 29, 2026 |
| ASX | 6-K | bullish | 6/10 | ASE Technology reported Q3 2026 results with strong revenue and earnings growth, and provided Q4 2026 guidance for conti | Oct 29, 2026 |
| RML | 6-K | neutral | 4/10 | Resolution Minerals Ltd filed its quarterly activities and cash flow report for the period ending September 30, 2026, hi | Oct 29, 2026 |
| ABEV | 6-K | neutral | 5/10 | Ambev reported Q3 2026 results with organic net revenue growth of 7.6% and Normalized EBITDA growth of 8.9%, driven by v | Oct 29, 2026 |
| CHWM | 6-K | neutral | 4/10 | Chilwa Minerals Ltd filed its September 2026 quarterly activities and cashflow report, detailing exploration progress at | Oct 29, 2026 |